Delivery Order SPE2DX22D0029-SPE2D826F08EC
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $79,064.32 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, which was not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,815.58 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $4,977.12 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, which is not a set-aside contract, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,413.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with ultimate completion by August 5, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger indefinite delivery vehicle, this award reflects AmerisourceBergen's role...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $46,475.04 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 29, 2025, with a completion deadline of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $11,248.75 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitive award, issued on November 9, 2025, with an ultimate completion date of November 10, 2025, utilizes firm fixed pricing with no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $17,005.64 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $27,275.82 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with completion scheduled for December 2, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,231.87 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with an ultimate completion date of December 9, 2025. This delivery order, which carries no set-aside designation, was competitively awarded on a firm fixed-price basis and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $20,193.60 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with completion expected by December 2, 2025. This firm fixed-price delivery order, which received no set-aside designation, represents a competitive award to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F08ECDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,440.48 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 3, 2025, with a completion date of December 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion comprehensive vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying an extensive portfolio of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contracts support military and veteran healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order exemplifies AmerisourceBergen's role as a primary pharmaceutical distributor under the DLA's global pharmaceutical support framework, which is evolving toward the Pharmaceutical Prime Vendor Global Program Generation V model anticipated to include multiple regional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 12/2/25 |